Interchangeability of different COVID-19 vaccine platforms as booster doses: A phase 3 study mimicking real-world practice. (PubMed, Vaccine) - May 19, 2024 - P3 | "Protein, adenovirus-vector or mRNA vaccine boosters were equally well tolerated and immunogenic against ancestor SARS-CoV-2 and Omicron sub-lineages in fully primed adults with 0-2 prior boosters. BNT162b induced the highest immune responses but also the most rapid waning of antibodies 3 months after vaccination."
Journal • P3 data • Real-world • Real-world evidence • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
|
|
Eveline P Milan; Igor Smolenov; Lily Weckx; Ralf Clemens; Sue Ann Costa Clemens
|